Astorg and Goldman Sachs in talks to sell HRA Pharma to Perrigo

Astorg and Goldman Sachs have entered into exclusive talks with as well as received a binding offer from Perrigo for the sale of HRA Pharma.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this